scholarly journals Gingival crevicular fluid levels of cytokine, chemokine, and growth factors in patients with periodontitis or gingivitis and periodontally healthy subjects: a cross-sectional multiplex study

Author(s):  
Hasan Gündogar ◽  
Kemal Üstün ◽  
Süleyman Ziya Şenyurt ◽  
Eda Çetin Özdemir ◽  
Ufuk Sezer ◽  
...  
2007 ◽  
Vol 78 (10) ◽  
pp. 1962-1967 ◽  
Author(s):  
A.R. Pradeep ◽  
Magesh S. Kumar ◽  
M.V. Ramachandraprasad ◽  
Chowdhry Shikha

2013 ◽  
Vol 49 (3) ◽  
pp. 282-289 ◽  
Author(s):  
A. S. Ertugrul ◽  
H. Sahin ◽  
A. Dikilitas ◽  
N. Z. Alpaslan ◽  
A. Bozoğlan ◽  
...  

2010 ◽  
Vol 37 (2) ◽  
pp. 180-190 ◽  
Author(s):  
Andrea M. Marcaccini ◽  
Cesar A. Meschiari ◽  
Leonardo R. Zuardi ◽  
Tiago Sampaio de Sousa ◽  
Mario Taba ◽  
...  

2015 ◽  
Vol 86 (12) ◽  
pp. 1396-1404 ◽  
Author(s):  
Umut Balli ◽  
Ahmet Aydogdu ◽  
Figen Ongoz Dede ◽  
Cigdem Coskun Turer ◽  
Berrak Guven

2021 ◽  
Vol 17 ◽  
Author(s):  
Consuelo Romero-Sánchez ◽  
Sebastián Giraldo ◽  
Ana María Heredia-P ◽  
Juliette De Avila ◽  
Lorena Chila-Moreno ◽  
...  

Background: The aim of this study was to assess DKK-1 levels, in Gingival Crevicular Fluid (GCF) and serum, as a biomarker for bone loss and disease activity in periodontitis and early RA (eRA). Methods: In this cross-sectional study, we obtained serum and GCF from 10 interproximal sites (Distal Buccal I/S, Mesio Buccal I/S, Distal Palatal/Lingual, Mesio Palatal/Lingual) according to the highest degree of inflammation by a patient for 240 sites from eRA patients. Patients received a periodontal assessment, a radiographic evaluation, tomography of interproximal sites, and DKK1 levels were determined by ELISA. Comparisons were performed by the Mann–Whitney U test and analysis by Chi2 test, and a logistic regression model was applied. Results: The mean age was 46.33 ± 12.0 years, the Disease Activity Score (DAS-28-ESR) was 4.08 ± 1.4. Periodontitis was present in 65.2% of the patients, and 59.6% of these patients had bone loss in interproximal sites. Higher GCF-DKK1 levels were associated with serum-DKK1 (OR:2.41 IC95% 1.14–5.09, p=0.021) and were related with DAS28-ESR (p=0.001), Routine Assessment of Patient Index Data 3 (RAPID 3) (p=0.001), and tender joints (p=0.040). Foot bone erosion and juxta-articular osteopenia were associated with high levels of serum-DKK1 (p=0.009 and 0.001, respectively). Serum-DKK1 were associated with SDAI (OR: 2.38 IC95% 1.03–5.52, p=0.043), RAPID 3 (p=0.001), and rheumatoid factor (p=0.018). The GCF-DKK1 levels were associated with periodontal bone loss (p=0.011), periodontitis (p=0.070) and its severity (OR: 2.58 IC95% 2.28–7.28, p=0.001). Bone loss was more frequent in buccal sites (73.5%) and was associated with increased levels of DKK1 (p=0.033). Conclusion: In the early stages of the eRA disease, serum and GCF-DKK1 could be a biomarker for clinical disease activity and periodontal and articular bone erosion.


Sign in / Sign up

Export Citation Format

Share Document